Page last updated: 2024-10-27

fluconazole and Neurodevelopmental Disorders

fluconazole has been researched along with Neurodevelopmental Disorders in 1 studies

Fluconazole: Triazole antifungal agent that is used to treat oropharyngeal CANDIDIASIS and cryptococcal MENINGITIS in AIDS.
fluconazole : A member of the class of triazoles that is propan-2-ol substituted at position 1 and 3 by 1H-1,2,4-triazol-1-yl groups and at position 2 by a 2,4-difluorophenyl group. It is an antifungal drug used for the treatment of mucosal candidiasis and for systemic infections including systemic candidiasis, coccidioidomycosis, and cryptococcosis.

Neurodevelopmental Disorders: These are a group of conditions with onset in the developmental period. The disorders typically manifest early in development, often before the child enters grade school, and are characterized by developmental deficits that produce impairments of personal, social, academic, or occupational functioning. (From DSM-5).

Research Excerpts

ExcerptRelevanceReference
"Invasive candidiasis is an important cause of sepsis in extremely low birth weight infants (ELBW, < 1000 g), is often fatal, and frequently results in neurodevelopmental impairment (NDI) among survivors."1.48Antifungal Susceptibility and Clinical Outcome in Neonatal Candidiasis. ( Adams-Chapman, I; Autmizguine, J; Benjamin, DK; Cohen-Wolkowiez, M; Cotten, CM; Goldberg, RN; Smith, PB; Stoll, BJ; Tan, S; Wiederhold, N, 2018)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Autmizguine, J1
Tan, S1
Cohen-Wolkowiez, M1
Cotten, CM1
Wiederhold, N1
Goldberg, RN1
Adams-Chapman, I1
Stoll, BJ1
Smith, PB1
Benjamin, DK1

Other Studies

1 other study available for fluconazole and Neurodevelopmental Disorders

ArticleYear
Antifungal Susceptibility and Clinical Outcome in Neonatal Candidiasis.
    The Pediatric infectious disease journal, 2018, Volume: 37, Issue:9

    Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis, Invasive; Cohort Studies; Drug Resistance,

2018